Home/Pipeline/Cerebro Platform for Pain

Cerebro Platform for Pain

Neuropathic Pain

Pre-clinicalActive

Key Facts

Indication

Neuropathic Pain

Phase

Pre-clinical

Status

Active

Company

Vonova.io

About Vonova.io

Vonova is pioneering a transvascular platform to revolutionize brain access by using the venous system, thereby avoiding the risks and invasiveness of traditional craniotomy. Founded in 2020 and based in San Francisco, the company's 'Cerebro Platform' is a guided neurovascular system designed to improve recovery times and expand treatment options for millions of patients with chronic neurological disorders. Having secured seed financing and recognition as a MedTech Innovator finalist, Vonova is positioned at the intersection of neuroscience and advanced device technology to address a significant unmet clinical need.

View full company profile

Therapeutic Areas

Chronic Subdural Hematoma Neuropathic Pain Epilepsy

Other Neuropathic Pain Drugs

Drug	Company	Phase	Status
Peripheral nerve pain agent	Nyrada	Preclinical	Active
NTRX-07	NeuroTherapia	Pre-clinical	Active
Neuropathic Pain Model Service	NeuroProof	Pre-clinical	Active
Sana Device for Neuropathic Pain	Sana Health	Pivotal Trial Completed	Active
Neuropathic Pain Program	VersaPeutics	Preclinical	Active
LAT9997	Lateral Pharma	Phase 2 (next-gen)	Active; composition-of-matter patent secured
ZYNPN	Zyneyro	Pre-clinical	Active
XT-150 (Preclinical)	Xalud Therapeutics	Preclinical	Active
ONO-2910	Ono Pharmaceutical	Phase 2	Active
VX-548	Vertex Pharmaceuticals	Phase 2	Active
BDT272	KYORIN Pharmaceutical	Preclinical	Active (In-licensed)
HSK16149	Haisco Pharmaceutical Group	Phase III	Active